Patents by Inventor Jeremy Blitzer

Jeremy Blitzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical for oral delivery comprising MGBG and methods of treating disease
    Patent number: 9616035
    Abstract: Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: April 11, 2017
    Assignee: PATHOLOGICA, LLC
    Inventors: John McKearn, Jeremy Blitzer
  • METHODS AND COMPOSITIONS FOR TREATMENT OF DEMYELINATING DISEASES
    Publication number: 20150359761
    Abstract: Disclosed herein are new oral pharmaceutical compositions of SAMDC inhibitors, polyamine analogs, and polyamine biosynthesis inhibitors, and their application for the treatment of conditions including demyelinating diseases, autoimmune disorders affecting the nervous system, and other neurodegenerative conditions.
    Type: Application
    Filed: January 8, 2014
    Publication date: December 17, 2015
    Inventors: Jeremy Blitzer, John McKearn
  • CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG
    Publication number: 20140377345
    Abstract: Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
    Type: Application
    Filed: September 9, 2014
    Publication date: December 25, 2014
    Inventors: John McKearn, Jeremy Blitzer
  • Delayed release oral pharmaceutical dosage forms comprising MGBG
    Patent number: 8858991
    Abstract: Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
    Type: Grant
    Filed: January 19, 2012
    Date of Patent: October 14, 2014
    Assignee: Pathologica LLC
    Inventors: John McKearn, Jeremy Blitzer
  • Method of Treatment with Anti-Inflammatory and Analgesic Compounds Which are GI-, Renal-, and Platelet-Sparing
    Publication number: 20140187643
    Abstract: Disclosed herein are compounds, pharmaceutical compositions, and methods for the treatment of diseases such as inflammation and/or pain, comprising the administration of a therapeutically effective amount of a non-steroidal, non-opioid compound having GI-/renal-/platelet-sparing activities, and wide safety margins with no appreciable inhibition of either form of cyclooxygenase.
    Type: Application
    Filed: September 23, 2013
    Publication date: July 3, 2014
    Applicant: PATHOLOGICA LLC
    Inventors: John McKearn, Jeremy Blitzer
  • PHARMACEUTICAL FOR ORAL DELIVERY COMPRISING MGBG AND METHODS OF TREATING DISEASE
    Publication number: 20140051765
    Abstract: Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.
    Type: Application
    Filed: October 25, 2013
    Publication date: February 20, 2014
    Applicant: PATHOLOGICA LLC
    Inventors: John McKearn, Jeremy Blitzer
  • Methods of treating pain with MGBG
    Patent number: 8609734
    Abstract: Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.
    Type: Grant
    Filed: July 24, 2012
    Date of Patent: December 17, 2013
    Assignee: Pathdogica, LLC
    Inventors: John McKearn, Jeremy Blitzer
  • PHARMACEUTICAL FOR ORAL DELIVERY COMPRISING MGBG AND METHODS OF TREATING DISEASE
    Publication number: 20120289604
    Abstract: Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.
    Type: Application
    Filed: July 24, 2012
    Publication date: November 15, 2012
    Applicant: PATHOLOGICA LLC
    Inventors: John McKearn, Jeremy Blitzer
  • CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG
    Publication number: 20120269891
    Abstract: Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.
    Type: Application
    Filed: January 19, 2012
    Publication date: October 25, 2012
    Applicant: PATHOLOGICA LLC
    Inventors: John McKearn, Jeremy Blitzer
  • Pharmaceutical for oral delivery comprising MGBG
    Patent number: 8258186
    Abstract: Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: September 4, 2012
    Assignee: Pathologica, LLC
    Inventors: John McKearn, Jeremy Blitzer
  • PHARMACEUTICAL FOR ORAL DELIVERY COMPRISING MGBG AND METHODS OF TREATING DISEASE
    Publication number: 20110112199
    Abstract: Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.
    Type: Application
    Filed: July 16, 2010
    Publication date: May 12, 2011
    Applicant: PATHOLOGICA LLC
    Inventors: John McKearn, Jeremy Blitzer